Buy Crypto Markets Spot FuturesGOLD Earn Event Center

Virax Biolabs Group Limited (VRAX)

NASDAQ

$0.22

$+0.05

(+32.92%)

Virax Biolabs Group Limited (VRAX) Live Price Chart

Page last updated: 2026-03-31 21:17:00

Key Market Data

Market Cap	$942.20K
Open	$0.25
High	$290.00
Low	$0.15
Previous Close	$0.16
Price Change	$+0.05
Percentage Change	+32.92%
Volume	234M

Virax Biolabs Group Limited (VRAX) Stock Price Today

Virax Biolabs Group Limited (VRAX) is currently trading at $0.22 as of 2026-03-31 21:17:00, reflecting a +32.92% move ($+0.05) from the previous close.

In the short term, the stock has returned -1.50% over the past four weeks. Over the last 12 months, Virax Biolabs Group Limited has recorded a -80.96% price change, indicating a weak performance relative to the broader market.

Virax Biolabs Group Limited (VRAX) 7-Day Stock Price Changes

Over the past seven days, Virax Biolabs Group Limited has traded within a short-term range shaped by market sentiment in the sector. During this period, the stock moved from its previous closing price of $0.19 to the latest recorded price of $0.22, reflecting an intraday change of +32.92%. Daily movements highlight shifts in trading volume (233,727,792), investor positioning, and reactions to macroeconomic updates.

From a momentum standpoint, VRAX has delivered a -1.50% return over the past month and a -80.96% change in the last 12 months, indicating a weak trend relative to its broader sector peers.

How to Buy Virax Biolabs Group Limited (VRAX)

You can buy and trade VRAX on MEXC in three simple steps:

Step 1: Create and Verify Your MEXC Account

Sign up on MEXC and complete the required identity verification (KYC). This ensures full access to trading features and secure funding options.

Step 2: Deposit Funds Into Your Account

Choose your preferred payment method to add USDT or other supported assets to your MEXC wallet. Depositing crypto is the fastest way to get started.

Step 3: Search for VRAX and Execute Your Trade

Open the trading page, enter VRAX in the search bar, select the amount of VRAX you would like to purchase. Place a market order for instant execution or a limit order to buy at your target price.

What is Virax Biolabs Group Limited (VRAX)?

Virax Biolabs Group Ltd is an inventive biotechnology company focused on the detection of immune responses to and diagnosis of viral diseases. Through its ViraxImmune platform and ImmuneSelect portfolio of research-use-only (RUO) products and services, the Company is building an immune-profiling offering that spans RUO assays, preclinical immunology services and, longer term, T cell-based diagnostics aimed at post-acute infection syndromes (PAIS) such as Long COVID and other chronic conditions linked to immune dysregulation.

Virax Biolabs Group Limited Information

Industry	--
Employees	19
Sector	--
Company Website	https://www.viraxbiolabs.com

Frequently Asked Questions (FAQ)

1.What is the current share price of Virax Biolabs Group Limited?

The latest trading price for Virax Biolabs Group Limited (Common Stock) is $ 0.22, compared with a previous closing price of $ 0.16. That means the stock has moved +32.92% so far today. Intraday price updates and recent trading activity for VRAX can be tracked on the live chart and quote section on this page.

2.Is Virax Biolabs Group Limited stock going up or down?

Looking at recent performances, VRAX has returned -1.50% over the past month, -64.80% over the last six months and -80.96% over the past year. These figures capture share-price changes only, not the impact of dividends. Together they describe weak price momentum for Virax Biolabs Group Limited stock, but keep in mind that past returns do not guarantee future results.

3.Where does VRAX currently sit relative to its 52-week high and low?

In the most recent 52-week period, Virax Biolabs Group Limited has traded between a low of $ 0.15 and a high of $ 1.34. This 52-week range helps show where today's share price sits relative to its recent highs and lows, and is often used by investors to judge stock volatility, potential support and resistance levels, and whether VRAX is currently nearer the top or the bottom of its one-year trading band.

4.How is Virax Biolabs Group Limited classified by sector and industry?

Virax Biolabs Group Limited is classified in the -- sector. In practice, this means Virax Biolabs Group Limited is grouped with other companies that serve similar end-markets and operate under comparable competitive and regulatory conditions. For investors, knowing VRAX’s sector helps with portfolio diversification, peer comparisons, and understanding how broader trends affecting the -- sector could influence Virax Biolabs Group Limited’s performance.

5.Where is Virax Biolabs Group Limited listed and how large is it by market value?

Virax Biolabs Group Limited is listed on the NASDAQ stock exchange in United States. Based on a market capitalization of $ 942.20K, the company is classified as a Small-cap stock. Market cap gives a quick sense of Virax Biolabs Group Limited's size and importance in the equity market and is often used by investors and index providers when constructing portfolios or benchmarks.

6.What does VRAX's EPS tell investors about its profitability?

Trailing-twelve-month EPS of -- summarises how much profit Virax Biolabs Group Limited has generated per share over the last year. Rising EPS over time can signal improving profitability or effective share repurchases, while flat or declining EPS may point to slower growth or margin pressure. EPS is a key input into valuation metrics such as P/E and is often monitored closely around earnings announcements.

7.How can I track Virax Biolabs Group Limited's financial performance over time?

To follow Virax Biolabs Group Limited's financial performance, investors typically review its quarterly and annual reports, which include detailed income statements, balance sheets and cash-flow statements. Combining these filings with key market data shown on this page—such as share price trends, P/E and dividend yield—provides a more complete view of how VRAX is performing and how the market is responding.

8.When is Virax Biolabs Group Limited expected to report earnings?

Virax Biolabs Group Limited's next scheduled earnings release is currently expected on -- (the date may be updated by the company). Earnings announcements often act as important catalysts for VRAX, as they provide updated information on revenue, profitability and management's outlook.

9.What usually comes out in Virax Biolabs Group Limited's earnings reports?

Virax Biolabs Group Limited's earnings reports typically include headline figures such as revenue, net income and EPS, along with commentary on segment performance, margins, cash flow and guidance for future periods. Investors compare these results with market expectations and prior periods to assess whether VRAX is meeting, beating or missing expectations.

10.How can I stay informed about Virax Biolabs Group Limited's results and guidance?

You can stay up to date on Virax Biolabs Group Limited by reviewing its quarterly earnings releases, listening to or reading transcripts of earnings calls, and following company news and filings. Pairing this fundamental information with the price and return data for VRAX on this page helps you see how new information is being reflected in the stock.

11.Does Virax Biolabs Group Limited pay a regular cash dividend to its shareholders?

Virax Biolabs Group Limited Non-paying. Based on the latest information, the stock has an indicated annual cash dividend of -- per share and a current dividend yield of -- at the recent share price. Dividends are typically paid --, although the board can change the dividend policy at any time. Income-focused investors often monitor VRAX's dividend level, payment frequency and any announcements about future dividends when assessing the stock's appeal as a dividend-paying investment.

12.What are the current dividend yield and dividend payout ratio for VRAX?

Based on the latest earnings data, VRAX has a dividend yield of -- and a dividend payout ratio of --. The dividend yield shows how much cash return an investor receives from dividends each year relative to the current share price, helping assess whether Virax Biolabs Group Limited is an attractive income stock. The dividend payout ratio measures what percentage of earnings Virax Biolabs Group Limited distributes to shareholders as dividends versus how much it retains to reinvest in the business, which is an important indicator of dividend sustainability and room for future dividend growth.

13.What kind of business is Virax Biolabs Group Limited?

Virax Biolabs Group Limited is a publicly traded company in the -- industry within the -- sector. It generates revenue from products and services related to this core business area, and investors can find a detailed description of its operations, strategy and geographic exposure in the company's annual report and other regulatory filings.

14.How is VRAX valued in terms of P/E ratio and EPS?

Virax Biolabs Group Limited currently trades at a price-to-earnings (P/E) ratio of --, based on trailing-twelve-month earnings per share (EPS) of --. P/E is calculated by dividing the share price by EPS and shows how much investors are paying today for each unit of Virax Biolabs Group Limited's earnings. Comparing VRAX's P/E and EPS to those of other -- companies can help investors judge whether its valuation looks rich or attractive.

Explore More US Stocks

Stocks in the Same Sector

Browse other US stocks in the same sector as Virax Biolabs Group Limited

The Walt Disney Company

DIS

Largest Market Cap

See US stocks with the highest market capitalization

Berkshire Hathaway Inc.

BRK.A

Alphabet Inc.

GOOG

Most Actively Traded

Discover today's most actively traded US stocks

CNX Resources Corporation

CNX

CareTrust REIT, Inc.

CTRE

CVR ENERGY, INC.

CVI

The Estee Lauder Companies Inc.

Kosmos Energy Ltd.

KOS

Top Gainers

Browse today's leading gainers in the US stock market

Apellis Pharmaceuticals, Inc.

APLS

Bullfrog AI Holdings, Inc.

BFRG

PMGC Holdings Inc.

ELAB

Frontier Nuclear and Minerals Inc.

FNUC

Globavend Holdings Limited

GVH

Top 5 Cryptocurrencies

Explore the cryptocurrencies with the highest market capitalization

BTC

ETH

SOL

Disclaimer

The stock price information displayed on this page is provided for reference purposes only and may be delayed or differ from real-time market data. Prices, charts, and related metrics do not constitute investment advice and should not be relied upon for trading or investment decisions. MEXC is not responsible for any losses incurred based on the stock price information provided on this page. Please refer to official market sources or consult licensed financial professionals before making any investment decisions.

VRAX-to-USD Calculator

Amount

VRAX

USD

1 VRAX = 0.217 USD